Immuron (IMRN) Cash from Operations (2016 - 2022)
Immuron (IMRN) posted Cash from Operations of -$992017.0 for Q4 2022, up 49.98% on a QoQ basis from -$2.0 million in Q4 2021, and up 49.98% year-over-year from -$661422.5 in Q4 2021.
Powered by 
Analysis
Immuron (IMRN) Cash from Operations (2016 - 2022) Analysis & Trends
Immuron has reported Cash from Operations for 7 years, with the latest figure at -$992017.0 in Q4 2022.
- On a quarterly basis, Cash from Operations rose 49.98% year-over-year to -$992017.0 in Q4 2022; TTM through Dec 2022 was -$7.2 million, a 8.49% decrease from a year earlier, with the FY2026 full-year figure at -$3.3 million, up 46.88% from the prior year.
- Cash from Operations was -$992017.0 for Q4 2022 at Immuron, up from -$2.0 million in the prior quarter.
- The five-year high for Cash from Operations was -$424940.0 in Q4 2018, with the low at -$2.7 million in Q4 2020.
- Average Cash from Operations over 5 years is -$1.5 million, with a median of -$1.6 million recorded in 2019.
- The sharpest annual moves came in 2018 and 2019: Cash from Operations soared 82.66% in 2018, then sank 268.06% in 2019.
- Over 5 years, Cash from Operations stood at -$424940.0 in 2018, then tumbled by 268.06% to -$1.6 million in 2019, then plunged by 73.23% to -$2.7 million in 2020, then rose by 26.8% to -$2.0 million in 2021, then surged by 49.98% to -$992017.0 in 2022.
- The last three Cash from Operations figures came in at -$992017.0 (Q4 2022), -$2.0 million (Q4 2021), and -$2.7 million (Q4 2020), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 4.00 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 3.57 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 1.13 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 813.00 Mn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | -526.00 Mn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | - |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 326.72 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 448.90 Mn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | -270.50 Mn |
| 10 | Immuron | 7.14 Mn | -1.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | -992,017.00 |
| Dec 31, 2021 | -1.98 Mn |
| Dec 31, 2020 | -2.71 Mn |
| Dec 31, 2019 | -1.56 Mn |
| Dec 31, 2018 | -424,940.00 |
| Dec 31, 2017 | -2.45 Mn |
| Dec 31, 2016 | 1.67 Mn |
API Access
Immuron Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=IMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "IMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=IMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();